Orient Pharma Co., Ltd. (TPEX: 4166)

Market Cap	8.55B
Revenue (ttm)	1.07B
Net Income (ttm)	119.10M
Shares Out	223.04M
EPS (ttm)	0.53
PE Ratio	71.82
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	222,567
Open	40.05
Previous Close	39.40
Day's Range	38.35 - 40.10
52-Week Range	19.45 - 50.70
Beta	0.15
Analysts	n/a
Price Target	n/a
Earnings Date	Nov 28, 2024

About Orient Pharma

Orient Pharma Co., Ltd. engages in the research and development, manufacturing, and sales of drugs in Taiwan and internationally. The company develops anti-psychotics and psychostimulants, as well as drugs for treating Parkinson’s and Alzheimer’s diseases; and products for the treatment of sialorrhea, tuberculosis, and attention deficit hyperactivity disorder. It is also developing drug delivery technologies, such as multi-stages-controlled release technology, trans-dermal patches, oral disintegrating tablets, sustained release technology, and ...

• Industry: Drug Manufacturers - Specialty & Generic
• Sector: Healthcare
• Founded: 2008
• Employees: 173
• Stock Exchange: Taipei Exchange
• Ticker Symbol: 4166